Telos Partners, LLC, together with First Security Bank and Accelerate Montana, present
“Crack the Code: 3 Defining Steps to Unlock Your Medical Technology’s Commercialization Potential”
This event will include an interactive panel presentation moderated by Telos Partners’ founder, Joel Batts, along with distinguished healthcare industry panelists from across the United States.
New to the panel is Michael Goguen (Philanthropist and Venture Capitalist) who has now turned his sights towards gene-editing technology that could be applied to Alzheimer’s, cancer, and other diseases. Mr. Goguen was a managing partner for the iconic Silicon Valley venture capital firm Sequoia Capital. Sequoia has backed companies such as Apple, Google, Oracle, PayPal, YouTube, and Instagram. During his time with Sequoia, Goguen also had spent time with gene-editing researchers.
Goguen will join 3 additional panelists, including Samir Bhattacharyya, PhD (Johnson & Johnson), Bill Cimino, PhD, (The GID Group) and Dennis O’Brien (Linn Grove Venture Capital). These subject matter experts will speak about their experiences in the medical world and how their successes and challenges can help Montanan’s who are also embarking on their own biomedical start-up journeys. There will also be information and resources regarding FDA regulation and reimbursement, technology adoption, intellectual property, funding, and distribution at this event.
Thursday, September 27th, 2018 from 4:30 PM – 8:30 PM
Gilkey Building – University of Montana, 950 Arthur Avenue, Missoula
Speakers and Panelists:
Joel Batts | MA President, Co-Founder Telos Partners, LLC
Joel is a medical device industry veteran, with 20 years of leadership experience developing scientific and regulatory strategies for start-ups to large-cap companies. He has delivered >$100 million return on investment by delivering FDA approvals for Class II and Class III devices in the musculoskeletal and wound care spaces. He has published and presented the results of pre-clinical and clinical science in journals such as American Journal of Sports Medicine, American Journal of Orthopaedics, and venues such as the American College of Foot and Ankle Surgeons. In 2010, he led a business development team in the application of a novel biologic material to osteoporotic patients for reducing the incidence of hip fractures. After conducting early-phase trials and developing the scientific and regulatory strategy, the team sold the technology for $30 million. He has also overseen key areas of investment and integration for four major acquisitions.
Samir Bhattacharyya, PhD | Head, Health Economics and Market Access, US Depuy Synthes
Dr. Bhattacharyya has 19 years of global experience in the medical device, pharmaceutical, and biotechnology industries. He has held leadership positions in sales and marketing, pricing and reimbursement, health economics & market access, and clinical research and development. Prior to joining Johnson & Johnson, Dr. Bhattacharyya was a vice president of market access services at Covance, a global contract research organization. He has previously served as senior director of marketing at Baxter Healthcare Corporation and has also worked for Amgen, Pfizer (Pharmacia), and Procter & Gamble. He has had many publications in peer-reviewed journals in the field of health economics and outcomes research. Dr. Bhattacharyya has completed several recognized leadership training programs including Harvard University leadership seminars, COMPASS Leadership, and the Dale Carnegie Leadership Course.
William Cimino | PhD, CEO, The GID Group
Established scientist, engineer, and CEO specializing in medical system design, clinical research, and strategic business planning/development. Over 30 years of professional experience, from Senior Engineer to CEO/Chairman, covering all aspects of medical device business including device design and technology development, clinical studies and assessment, regulatory affairs, strategic market development, distribution, business management/growth, and financial/funding requirements. Experienced CEO of successful medical device startups, having designed and introduced to market over 50 different medical products/accessories including capital products and disposables, with over 30 issued US patents.
Michael Goguen | Philanthropist & Venture Capitalist
Michael is passionate about making as positive an impact as possible on the lives of others – as a philanthropist, a venture capitalist, and as a first responder. After a 30 year career as a leading technologist and venture capitalist in silicon valley, Michael now resides full-time in Montana. He’s focused on finding solutions to local and state-wide challenges to improve the lives of MT residents, and on helping great entrepreneurs start and build new and innovative companies that positively impact us all. During a nearly 20 year career at Sequoia Capital, Michael led approximately 50 early and growth stage technology investments with many highly successful exits. Prior to Sequoia Michael spent 10 years in various engineering, research, and product management roles at DEC, SynOptics and Centillion, and was a director of Engineering at Bay Networks (NT).
Dennis O’Brien | Partner, Linn Grove Venture Capital & President/Chairman, Next Healthcare
Managing Director of Linn Grove Angel Fund 3, the current investment vehicle of Linn Grove Ventures. Chairman and President of Next Healthcare, a North Dakota cell therapeutics start-up offering CelBank service. Founder and President of D O’Brien and Associates, LLC, a strategic consulting and investment advisor in the Medtech market. Dennis has a broad leadership background in manufacturing and marketing in the medical device industry. Before starting his own firm, he spent 16 years with Bausch and Lomb as General Manager of Canadian operations, Vice President of Global Refractive Surgery and, most recently, as VP and GM of US Surgical operations. These roles have given Dennis vast medical experience in strategic marketing, including developing and managing supplier agreements, license agreements and strategic acquisitions. He is also highly knowledgeable in the areas of manufacturing, domestic and international logistics, upstream marketing and strategy, and commercial operations.
Seating is limited in the Gilkey Building, so we highly recommend registering as soon as possible.
For more questions, please contact Cassandra Sunell at firstname.lastname@example.org.